Cleveland Heartlab
-
Quest Diagnostics’ Cleveland HeartLab acquisition reflects personalized medicine trend
In addition to the acquisition, Quest Diagnostics and the Cleveland Clinic have embarked on a strategic collaboration that will evaluate biomarkers for various diseases, with Quest developing tests for some of them.
-
Diagnostics, Hospitals, Startups
Poised for more growth, Cleveland HeartLab adds $14.7 million and a new investor
Biomarker testing firm Cleveland HeartLab is still growing fast, and it doesn’t plan on slowing […]
-
Trayt Health Seeks to Increase Access to Diagnoses and Treatments
CEO Malekeh Amini explains how Trayt Health can bridge the gap for patients seeking neurological care.
-
Cleveland HeartLab named Ohio Venture Association’s venture of the year
Cardiac inflammation biomarker test company Cleveland HeartLab has been tapped as the Ohio Venture Association‘s […]
-
Cleveland HeartLab at TEDMED (video)
Biomarker test company Cleveland HeartLab made a splash recently at TEDMED, with about 500 conference-goers […]
-
Biomarker test firm Cleveland HeartLab eyes health and wellness market
After making major inroads among community-based physicians, cardiac inflammation biomarker test company Cleveland HeartLab is […]
-
Landing angel investment: 5 tips from those who’ve done it
Landing angel investment involves a little bit more than calling up a bunch of rich […]
-
Cleveland HeartLab to sign lease to nearly quadruple office space
Fresh off an $18 million fundraise, biomarker testing company Cleveland HeartLab plans today to sign […]
-
Biomarker test firm Cleveland HeartLab closes $18.4M investment
Biomarker test-maker Cleveland HeartLab has closed an $18.4 million series B round of funding, which […]
-
Biomarker test firm Cleveland HeartLab rejects buyer, picks ‘home’
Cleveland HeartLab, which makes a biomarker-based heart test, has rebuffed an acquisition offer and instead […]
-
Improving Communication Between Patients and Providers
Sarah Shillington, Chief Customer Officer notes how Artera’s omnichannel platform works.
-
Cleveland reputation for biotech innovation is growing
Cleveland is already well-known for its high quality medical care. But its reputation is growing […]
-
Cleveland HeartLab business has ‘exploded’ (in a good way)
In the words of Cleveland HeartLab CEO Jake Orville, business has “exploded” since the beginning of the year, just months after his company launched a proprietary test for cardiac inflammation under a fee-for-service model. Cleveland HeartLab is a CLIA-certified and CAP-accredited reference lab that does an array of lipid and inflammation tests for clients, including CardioMPO, a proprietary test for cardiac inflammation marker myeloperoxidase.
-
Cleveland HeartLab hosts ‘Where Inflammation Meets Lipids’
Tommy G. Thompson, former secretary of the U.S. Department of Health and Human Services-turned-healthcare consultant, […]
-
Cleveland HeartLab adds ‘bad cholesterol’ test to its portfolio
Cleveland HeartLab LLC has added a test of low-density lipoprotein, the so-called “bad cholesterol,” to […]
-
Cleveland HeartLab: How to go to market with diagnostic test?
Updated 4:29 p.m., March 18, 2010 The cardiac inflammation biomarker developed by Dr. Stanley Hazen […]
-
Cleveland HeartLab completes $3M funding to expand, develop more inflammation tests
Updated 4:24 p.m. Cleveland Clinic spinoff Cleveland HeartLab has completed a $3 million fundraising round, […]